Apple risks breaking a 14-quarter growth streak during the peak holiday period as chaotic conditions at its assembly plant in China hit iPhone production, marking the company’s biggest supply chain challenge since the onset of the pandemic. Analysts have been cutting Apple earnings estimates after the group issued a rare warning on November 6 that manufacturer…
Read more
More than half of UK civil servants have warned their departments lack the technological tools, resources and skills necessary to transform public services, according to a government-backed survey. Earlier this year, ministers set out a “road map” to improve digital public services by 2025, with the ambition to deliver “world-class” systems and “attract and retain…
Read more
You’re a hedge fund manager with a big idea. US lawyers are recruiting plaintiffs for a class action that echoes one of the great short trades in recent years. You have spotted the angle but it seems the wider financial community has not. You short the companies involved, of course. But court procedure moves at…
Read more
We’ve had antioxidants. We’ve had paleo, keto and hormetic stressors. But those are small fry compared to epigenetics, the latest watchword of the wellness industry, which is currently being slapped onto supplements, face creams and most anything related to longevity. Epigenetic tests are also offered at top-end Swiss-clinic health programmes, or via a kit you spit into…
Read more
Edited excerpts from the book proposals of the three finalists for the 2022 Bracken Bower Prize The Unstoppable Rise of Private Capital in Public Health How businesses can help or harm the future of healthcare BY VICTORIA BERQUIST The writer is a doctor, adviser to public and private healthcare organisations across several geographies, and is completing…
Read more
Just weeks ago at the company’s headquarters, Haruo Naito, the 74-year-old chief executive of Japan’s Eisai, was feeling vindicated after almost four decades of trying to develop an Alzheimer’s drug. Ahead of the release of detailed information on Eisai’s new drug lecanemab, developed with Biogen, the company’s share price surged 60 per cent after results…
Read more
The UK government is scrapping controversial powers to force internet companies to take down “legal but harmful” content, following a backlash from the tech industry and free speech advocates. The measure had been expected to form part of the long-awaited Online Safety Bill and would have represented a radical departure from existing global rules that…
Read more
Sen. Marsha Blackburn (R-Tenn.) took the stage at the “Rally to End Child Mutilation” in Nashville, Tennessee, last month in front of protesters, including far-right Proud Boys, to endorse the message that Vanderbilt University Medical Center was maiming children and needed to be stopped. “To protect our children,” a chorus of state legislators and conservative pundits repeated…
Read more
Elon Musk has claimed that Apple is curbing advertising on Twitter and threatening to “withhold” the social media platform from its App Store, as the world’s richest man locks horns with the most valuable tech company. In a flurry of more than a dozen tweets on Monday focused on the iPhone maker, Musk wrote that…
Read more
Quincy Medical Group is moving forward with plans to build a small-format hospital in Quincy, Ill., after a court dismissed an appeal filed by neighboring Blessing Health System to block the project. QMG’s new hospital will include 25 medical surgical beds, three labor, delivery, recovery and postpartum rooms, an emergency department with 10 bays, three…
Read more